Putting the award page together from the records…
Putting the award page together from the records…
CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
11 actions since 2022-12-22. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-04-14 | P00020 | Supplemental agreement (work within scope) | $10.36M | PHASE III CLINICAL TRIALS |
| 2026-01-28 | P00019 | Funding only | $6.75M | PHASE III CLINICAL TRIALS |
| 2025-11-25 | P00018 | Funding only | -$6.75M | PHASE III CLINICAL TRIALS |
| 2025-03-31 | P00017 | Supplemental agreement (work within scope) | $6.75M | PHASE III CLINICAL TRIAL FOR CRYOPERSERVED PLATLETS |
| 2024-11-27 | P00016 | Funding only | $9.06M | PHASE II CLINICAL TRIAL |
| 2024-11-25 | P00015 | Funding only | -$2.1K | PHASE II CLINICAL TRIAL |
| 2024-06-05 | P00014 | Supplemental agreement (work within scope) | $0 | PHASE II CLINICAL TRIAL |
| 2024-03-08 | P00013 | Supplemental agreement (work within scope) | $22.06M | PHASE II CLINICAL TRIAL |
| 2023-10-11 | P00012 | Funding only | $1.12M | PHASE II CLINICAL TRIAL |
| 2023-04-26 | P00011 | Supplemental agreement (work within scope) | $4.83M | PHASE II CLINICAL TRIAL |
| 2022-12-22 | P00010 | Supplemental agreement (work within scope) | $207.6K | PHASE II CLINICAL TRIAL INCREMENTAL FUND CLIN 0001 PER SECTION 711 OF THE 2019 NDAA, USAMRAA TRANSFERRED TO DHA 10/1/2022. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-20). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗